Clinical Trials Directory

Trials / Sponsors / Geron Corporation

Geron Corporation

Industry · 16 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Comb
Myelofibrosis
Phase 12022-05-04
Active Not RecruitingA Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk My
Myelofibrosis
Phase 32021-04-12
Active Not RecruitingStudy to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low
Myelodysplastic Syndromes
Phase 2 / Phase 32016-01-12
CompletedStudy to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Mye
Myelofibrosis
Phase 22015-08-28
CompletedImetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis
Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies
Phase 22012-10-29
CompletedOpen Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycyth
Essential Thrombocythemia, Polycythemia Vera
Phase 22010-12-01
CompletedImetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or
Locally Recurrent or Metastatic Breast Cancer
Phase 22010-11-01
CompletedOpen Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple
Multiple Myeloma
Phase 22010-11-01
CompletedImetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 22010-05-01
CompletedSafety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma
Multiple Myeloma
Phase 12008-07-01
CompletedA Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Brea
Breast Cancer
Phase 12008-07-01
CompletedSafety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma
Multiple Myeloma
Phase 12007-11-01
CompletedStudy of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung C
Lung Cancer
Phase 12007-07-01
CompletedSafety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies
Solid Tumor Malignancies
Phase 12006-03-01
CompletedSafety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)
Chronic Lymphoproliferative Diseases
Phase 12005-07-01
Approved For MarketingExpanded Access for Treatment With Imetelstat
Myelodysplastic Syndromes
——
Geron Corporation — clinical trials (16) · Clinical Trials Directory